Home ›
Trademark Categories ›
Pharmaceuticals ›
2012 ›
EF ›
EFILGA
Trademark search for:
EFILGA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2012-10-19 — Application filed
2012-10-23 — Application filed
2012-10-24 — Application filed
2013-02-18 — Assigned to examiner
2013-02-19 — Approved for pub - principal register
2013-03-06 — Notification of notice of publication e-mailed
2013-03-26 — Published for opposition
2013-03-26 — Official gazette publication confirmation e-mailed
2013-05-21 — Noa e-mailed - sou required from applicant
2013-11-13 — Sou teas extension received
2013-11-13 — Sou extension 1 filed
2013-11-13 — Sou extension 1 granted
2013-11-15 — Notice of approval of extension request e-mailed
2014-05-20 — Sou teas extension received
2014-05-20 — Sou extension 2 filed
2014-06-09 — Case assigned to intent to use paralegal
2014-06-10 — Sou extension 2 granted
2014-06-11 — Notice of approval of extension request e-mailed
2014-11-14 — Sou teas extension received
2014-11-14 — Sou extension 3 filed
2014-11-24 — Sou extension 3 granted
2014-11-25 — Notice of approval of extension request e-mailed
2015-06-22 — Application abandoned
2015-06-22 — Application abandoned
2015-06-22 — Final status recorded
Owner Information
Apotex Technologies Inc.
Toronto, Ontario CA
Apotex Technologies Inc.
Toronto, Ontario CA
Correspondent
ROBERT W. ADAMS NIXON & VANDERHYE, PC. 901 N GLEBE RD FL 11 ARLINGTON, VA 22203-1853 UNITED STATES
Filing Details
Filing Date:
2012-10-19
Status Date:
2015-06-22
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.